
KRAS - Wikipedia
KRAS (Kirsten rat sarcoma virus) is a gene that provides instructions for making a protein called K-Ras, a part of the RAS/MAPK pathway. The protein relays signals from outside the cell to the cell's nucleus.
What’s new in KRAS mutation research? - MD Anderson Cancer …
2024年4月4日 · The most frequently mutated of these oncogenic driver genes, called KRAS, is associated with some of the most fatal cancer types: lung, pancreatic and colorectal cancers.
KRAS mutation: from undruggable to druggable in cancer
2021年11月15日 · As the most frequently mutated oncogene, Kirsten rat sarcoma viral oncogene homologue (KRAS) has attracted substantial attention. The understanding of KRAS is constantly being updated by numerous...
KRAS gene - MedlinePlus
The KRAS gene provides instructions for making a protein called K-Ras that is part of a signaling pathway known as the RAS/MAPK pathway. The protein relays signals from outside the cell to the cell's nucleus.
KRAS Gene - GeneCards | RASK Protein | RASK Antibody
2024年12月25日 · KRAS (KRAS Proto-Oncogene, GTPase) is a Protein Coding gene. Diseases associated with KRAS include Schimmelpenning-Feuerstein-Mims Syndrome and Oculoectodermal Syndrome. Among its related pathways are Downstream signaling of activated FGFR2 and Prolactin Signaling.
Targeting KRAS in cancer - Nature Medicine
2024年4月18日 · Herein, we outline RAS pathobiology with a focus on KRAS, illustrate therapeutic approaches across a variety of malignancies, including emphasis on the ‘on’ and ‘off’ switch allele-specific and...
The current understanding of KRAS protein structure and dynamics
GTPase KRas (KRAS) is a signal transducer protein, which plays an important role in various cellular signalling events such as in regulation of cell proliferation. It is a critical hub in the cell circuitry, as upon an upstream stimulus it transduces activating signals to several cellular signalling pathways, including the mitogen-activated ...
KRAS Mutations in Solid Tumors: Characteristics, Current …
Kristen rat sarcoma (KRAS) gene is one of the most common mutated oncogenes in solid tumors. Yet, KRAS inhibitors did not follow suit with the development of targeted therapy, for the structure of KRAS has been considered as being implausible to target for decades.
Drugging mutant KRAS by disrupting binding to effectors and GTP
2 天之前 · Although enhancing the GTPase activity of KRAS is an attractive approach to inhibit constitutively active, GTP-bound mutant KRAS, so far this has not been achieved. Now, a RAS inhibitor thought to ...
KRAS Cancer Kickers | KRAS cancer biomarker research advocate
KRAS Kickers is a lung cancer research advocate community. KRAS is the most common biomarker associated with lung, colorectal, plus other cancers. Find resources to help with treatment.